Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | RPS6KA1 |
| Upstream (Parents) |
|---|
| (<<) ACTB → RPS6KA1 |
| (<<) DVL1 → RPS6KA1 |
| (<<) EMP1 → RPS6KA1 |
| (<<) INF2 → RPS6KA1 |
| (<<) MAP3K1 → RPS6KA1 |
| (<<) MAP3K11 → RPS6KA1 |
| (<<) MYC → RPS6KA1 |
| (<<) NET1 → RPS6KA1 |
| (<<) PRKCZ → RPS6KA1 |
| (<<) PRPF4B → RPS6KA1 |
| (<<) PTK2 → RPS6KA1 |
| (<<) TSPAN3 → RPS6KA1 |
| (<<) UBE2N → RPS6KA1 |
| (<<) YWHAZ → RPS6KA1 |
| Downstream (Children) |
|---|
| RPS6KA1 → CLK3 (>>) |
| RPS6KA1 → CXADR (>>) |
| RPS6KA1 → F2RL1 (>>) |
| RPS6KA1 → FOXC2 (>>) |
| RPS6KA1 → GNG5 (>>) |
| RPS6KA1 → GSTZ1 (>>) |
| RPS6KA1 → KHDRBS1 (>>) |
| RPS6KA1 → MST1R (>>) |
| RPS6KA1 → NAB2 (>>) |
| RPS6KA1 → PCSK7 (>>) |
| RPS6KA1 → PLA2G4C (>>) |
| RPS6KA1 → PRDX6 (>>) |
| RPS6KA1 → SLC25A32 (>>) |
| RPS6KA1 → SOCS2 (>>) |
| RPS6KA1 → TMEM39B (>>) |
| RPS6KA1 → TUBA4A (>>) |
